Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Contemporary Clinical Trials|December 6, 2014
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority studyReinaldo de Menezes Martins, Birute Curran, Maria de Lourdes Sousa Maia, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccinationMaria Luiza Silva, Luçandra Ramos Espírito-Santo, Marina Angela Martins, et al.
Vaccine|July 8, 2025
Immunogenicity, safety and immunological memory of a Brazilian meningococcal C conjugate vaccine on a phase II clinical trialReinaldo de Menezes Martins, Célia Menezes Cruz Marques, Tatiana Guimarães de Noronha, et al.
Vaccine|August 6, 2016
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety dataStefania Vergnano, Jim Buttery, Ben Cailes, et al.
The Journal of Infectious Diseases|August 19, 2011
Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibodyMaria Luiza-Silva, Ana Carolina Campi-Azevedo, Maurício Azevedo Batista, et al.
Emerging Infectious Diseases|July 13, 2019
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, BrazilAna Carolina Campi-Azevedo, Vanessa Peruhype-Magalhāes, Jordana Grazziela Coelho-Dos-Reis, et al.
Plos One|December 20, 2012
17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated childrenAna Carolina Campi-Azevedo, Luiza Pacheco de Araújo-Porto, Maria Luiza-Silva, et al.
Frontiers in Immunology|July 12, 2019
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology|November 8, 2019
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever VaccineIsmael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Plos Neglected Tropical Diseases|June 8, 2018
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccinationChristiane Costa-Pereira, Ana Carolina Campi-Azevedo, Jordana Grazziela Coelho-Dos-Reis, et al.
Pageof 3